Policy Statement-Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia

被引:172
作者
Watterberg, Kristi L.
Papile, Lu-Ann
Adamkin, David H.
Baley, Jill E.
Bhutani, Vinod K.
Carlo, Waldemar A.
Kumar, Praveen
Polin, Richard A.
Tan, Rosemarie C.
Wang, Kasper S.
Watterberg, Kristi L.
机构
关键词
bronchopulmonary dysplasia; preterm infant; glucocorticoid; dexamethasone; chronic lung disease; CHRONIC LUNG-DISEASE; BIRTH-WEIGHT INFANTS; EARLY ADRENAL INSUFFICIENCY; LOW-DOSE DEXAMETHASONE; NEONATAL HYDROCORTISONE TREATMENT; PLACEBO-CONTROLLED TRIAL; PRETERM INFANTS; FOLLOW-UP; RANDOMIZED-TRIAL; SCHOOL-AGE;
D O I
10.1542/peds.2010-1534
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The purpose of this revised statement is to review current information on the use of postnatal glucocorticoids to prevent or treat bronchopulmonary dysplasia in the preterm infant and to make updated recommendations regarding their use. High-dose dexamethasone (0.5 mg/kg per day) does not seem to confer additional therapeutic benefit over lower doses and is not recommended. Evidence is insufficient to make a recommendation regarding other glucocorticoid doses and preparations. The clinician must use clinical judgment when attempting to balance the potential adverse effects of glucocorticoid treatment with those of bronchopulmonary dysplasia. Pediatrics 2010;126:800-808
引用
收藏
页码:800 / 808
页数:9
相关论文
共 73 条
[22]   DNA, GANGLIOSIDE AND SULFATIDE IN BRAINS OF RATS GIVEN CORTICOSTERONE IN INFANCY, WITH AN ESTIMATE OF CELL LOSS DURING DEVELOPMENT [J].
HOWARD, E ;
BENJAMINS, JA .
BRAIN RESEARCH, 1975, 92 (01) :73-87
[23]   Effects of neonatal corticosteroid treatment on hippocampal synaptic function [J].
Huang, Chiung-Chun ;
Lin, Hsiue-Ru ;
Liang, Ying-Ching ;
Hsu, Kuei-Sen .
PEDIATRIC RESEARCH, 2007, 62 (03) :267-270
[24]   Adrenal function in sick very preterm infants [J].
Huysman, MWA ;
Hokken-Koelega, ACS ;
De Ridder, MAJ ;
Sauer, PJJ .
PEDIATRIC RESEARCH, 2000, 48 (05) :629-633
[25]   Hippocampal volume and everyday memory in children of very low birth weight [J].
Isaacs, EB ;
Lucas, A ;
Chong, WK ;
Wood, SJ ;
Johnson, CL ;
Marshall, C ;
Vargha-Khadem, F ;
Gadian, DG .
PEDIATRIC RESEARCH, 2000, 47 (06) :713-720
[26]   Randomized, controlled trial of dexamethasone in neonatal chronic lung disease: 13- to 17-year follow-up study: I. Neurologic, psychological, and educational outcomes [J].
Jones, RAK .
PEDIATRICS, 2005, 116 (02) :370-378
[27]   Neonatal dexamethasone treatment for chronic lung disease of prematurity alters the hypothalamus-pituitary-adrenal axis and immune system activity at school age [J].
Karemaker, Rosa ;
Kavelaars, Annemieke ;
ter Wolbeek, Maike ;
Tersteeg-Kamperman, Marijke ;
Baerts, Wim ;
Veen, Sylvia ;
Samsom, Jannie F. ;
Visser, Gerard H. A. ;
van Bel, Frank ;
Heijnen, Cobi J. .
PEDIATRICS, 2008, 121 (04) :E870-E878
[28]   Differences in behavioral outcome and motor development at school age after neonatal treatment for chronic lung disease with dexamethasone versus hydrocortisone [J].
Karemaker, Rosa ;
Heijnen, Cobi J. ;
Veen, Sylvia ;
Baerts, Wim ;
Samsom, Janny ;
Visser, Gerard H. A. ;
Kavelaars, Annemieke ;
van Doornen, Lorenz J. P. ;
van Bel, Frank .
PEDIATRIC RESEARCH, 2006, 60 (06) :745-750
[29]   Outcomes of extremely low birth weight (<1 kg) and extremely low gestational age (<28 weeks) infants with bronchopulmonary dysplasia:: Effects of practice changes in 2000 to 2003 [J].
Kobaly, Kristen ;
Schluchter, Mark ;
Minich, Nori ;
Friedman, Harriet ;
Taylor, Hudson Gerry ;
Wilson-Costello, Deanne ;
Hack, Maureen .
PEDIATRICS, 2008, 121 (01) :73-81
[30]   Structural and functional brain development after hydrocortisone treatment for neonatal chronic lung disease [J].
Lodygensky, GA ;
Rademaker, K ;
Zimine, S ;
Gex-Fabry, M ;
Lieftink, AF ;
Lazeyras, F ;
Groenendaal, F ;
de Vries, LS ;
Huppi, PS .
PEDIATRICS, 2005, 116 (01) :1-7